sanofi vicebio - Search News

News

Sanofi, Vicebio

The Wall Street Journal on MSN · 1d

Sanofi to Buy Vaccine Developer Vicebio for Up to $1.6 Billion

The deal seeks to strengthen the drugmaker’s portfolio of respiratory vaccines and help it move on from pipeline setbacks.

Reuters on MSN · 1d

France's Sanofi to acquire biotech firm Vicebio for $1.15 billion

(Reuters) -French pharmaceuticals company Sanofi said on Tuesday it would acquire British private biotechnology firm Vicebio for a total of $1.15 billion, expanding its respiratory vaccine portfolio.

Seeking Alpha on MSN · 1d

Sanofi to acquire Vicebio in $1.6 billion deal to boost respiratory portfolio

Vicebio, a biopharmaceutical company developing novel vaccines against life-threatening respiratory viral infections, has entered an exclusive, definitive agreement to be acquired by Sanofi (SNY).

Fierce Biotech1d

Sanofi tightens grip on RSV, paying $1.15B upfront for Vicebio and boosting its pipeline beyond mRNA

Sanofi has struck a deal to buy Vicebio for $1.15 billion upfront, securing preclin | Sanofi has struck a deal to buy Vicebio ...

1d

Sanofi to Buy Vicebio for Up to $1.6 Billion in Vaccine Push

Sanofi agreed to buy UK vaccine developer Vicebio Ltd. for as much as $1.6 billion, as it seeks to expand in respiratory ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results